Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study
Titel:
Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study
Auteur:
Flippot, Ronan Telli, Tugce Velev, Maud Fléchon, Aude De Vries-Brilland, Manon Turpin, Léa Bergman, Andries Turco, Fabio Mahammedi, Hakim Fendler, Wolfgang P. Giraudet, Anne-Laure Josset, Quentin Montravers, Françoise Vogel, Wouter Gillessen, Silke Berardi Vilei, Simona Herrmann, Ken Kryza, David Paone, Gaetano Hadaschik, Boris Merlin, Charles Dufour, Pierre-Alban Bernard-Tessier, Alice Naoun, Natacha Patrikidou, Anna Garcia, Camilo Foulon, Stéphanie Pagès, Arnaud Fizazi, Karim